Outcomes measures in idiopathic intracranial hypertension

Research output: Contribution to journalArticlepeer-review

Standard

Outcomes measures in idiopathic intracranial hypertension. / Mollan, Susan; Sinclair, Alex.

In: Expert Review of Neurotherapeutics, 28.05.2021.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Bibtex

@article{f68c996935014d68964e1977e3fe24b3,
title = "Outcomes measures in idiopathic intracranial hypertension",
abstract = "IntroductionIdiopathic Intracranial Hypertension is condition characterised by raised intracranial pressure, papilledema, and normal neuroimaging (aside from radiological signs of raised intracranial pressure). Symptoms of idiopathic intracranial hypertension include chronic headaches and for some, visual loss. New treatments are an unmet clinical need.Areas coveredThe aim of this review is to present the evidence base and considered opinion on outcome measures to determine successful management of idiopathic intracranial hypertension.Expert opinionLess invasive measures of disease activity such as optical coherence tomography will continue to grow in this field, both as a measure of papilledema, and potentially as a surrogate for intracranial pressure and visual function. As a highly disabling aspect of the disease is headache, treatment outcomes for headache morbidity need to be appropriately chosen and standardized to allow comparison between trials.",
author = "Susan Mollan and Alex Sinclair",
year = "2021",
month = may,
day = "28",
doi = "10.1080/14737175.2021.1931127",
language = "English",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Informa Healthcare",

}

RIS

TY - JOUR

T1 - Outcomes measures in idiopathic intracranial hypertension

AU - Mollan, Susan

AU - Sinclair, Alex

PY - 2021/5/28

Y1 - 2021/5/28

N2 - IntroductionIdiopathic Intracranial Hypertension is condition characterised by raised intracranial pressure, papilledema, and normal neuroimaging (aside from radiological signs of raised intracranial pressure). Symptoms of idiopathic intracranial hypertension include chronic headaches and for some, visual loss. New treatments are an unmet clinical need.Areas coveredThe aim of this review is to present the evidence base and considered opinion on outcome measures to determine successful management of idiopathic intracranial hypertension.Expert opinionLess invasive measures of disease activity such as optical coherence tomography will continue to grow in this field, both as a measure of papilledema, and potentially as a surrogate for intracranial pressure and visual function. As a highly disabling aspect of the disease is headache, treatment outcomes for headache morbidity need to be appropriately chosen and standardized to allow comparison between trials.

AB - IntroductionIdiopathic Intracranial Hypertension is condition characterised by raised intracranial pressure, papilledema, and normal neuroimaging (aside from radiological signs of raised intracranial pressure). Symptoms of idiopathic intracranial hypertension include chronic headaches and for some, visual loss. New treatments are an unmet clinical need.Areas coveredThe aim of this review is to present the evidence base and considered opinion on outcome measures to determine successful management of idiopathic intracranial hypertension.Expert opinionLess invasive measures of disease activity such as optical coherence tomography will continue to grow in this field, both as a measure of papilledema, and potentially as a surrogate for intracranial pressure and visual function. As a highly disabling aspect of the disease is headache, treatment outcomes for headache morbidity need to be appropriately chosen and standardized to allow comparison between trials.

U2 - 10.1080/14737175.2021.1931127

DO - 10.1080/14737175.2021.1931127

M3 - Article

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

ER -